|
Originally published In Press as doi:10.1074/jbc.M200511200 on April 25, 2002
J. Biol. Chem., Vol. 277, Issue 26, 23627-23637, June 28, 2002
Oxyopinins, Large Amphipathic Peptides Isolated from
the Venom of the Wolf Spider Oxyopes kitabensis with
Cytolytic Properties and Positive Insecticidal Cooperativity with
Spider Neurotoxins*
Gerardo
Corzo §,
Elba
Villegas ,
Froylan
Gómez-Lagunas¶,
Lourival D.
Possani ,
Olga S.
Belokoneva , and
Terumi
Nakajima
From the Suntory Institute for Bioorganic
Research, Mishima-Gun, Shimamoto-Cho, Wakayamadai 1-1-1, Osaka
618-8503, Japan, the ¶ Department of Physiology, School of
Medicine, National Autonomous University of Mexico (UNAM), Cd.
Universitaria, Mexico City 04510, Mexico, and the Department of
Molecular Recognition and Structural Biology, Institute of
Biotechnology, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
Received for publication, January 17, 2002, and in revised form, April 25, 2002
 |
ABSTRACT |
Five amphipathic peptides with antimicrobial,
hemolytic, and insecticidal activity were isolated from the crude venom
of the wolf spider Oxyopes kitabensis. The peptides, named
oxyopinins, are the largest linear cationic amphipathic peptides from
the venom of a spider that have been chemically characterized at
present. According to their primary structure Oxyopinin 1 is composed
of 48 amino acid residues showing extended sequence similarity to the
ant insecticidal peptide ponericinL2 and to the frog antimicrobial peptide dermaseptin. Oxyopinins 2a, 2b, 2c, and 2d have highly similar
sequences. At least 27 out of 37 amino acid residues are conserved.
They also show a segment of sequence similar to ponericinL2. Circular
dichroism analyses showed that the secondary structure of the five
peptides is essentially -helical. Oxyopinins showed disrupting
activities toward both biological membranes and artificial vesicles,
particularly to those rich in phosphatidylcholine. Electrophysiological recordings performed on insect cells (Sf9) showed that the
oxyopinins produce a drastic reduction of cell membrane resistance by
opening non-selective ion channels. Additionally, a new paralytic
neurotoxin named Oxytoxin 1 was purified from the same spider venom. It
contains 69 amino acid residue cross-linked by five disulfide bridges. Application of mixtures containing oxyopinins and Oxytoxin 1 to insect
larvae showed a potentiation phenomenon, by which an increase lethality
effect is observed. These results suggest that the linear amphipathic
peptides in spider venoms and neuropeptides cooperate to capture
insects efficiently.
 |
INTRODUCTION |
Amphipathic and cationic -helical peptides are broadly found in
animals as a part of their biological defense system (1). Since the
discovery of melittins (2) and cecropins (3) a large number of
amphiphilic and cationic peptides have been characterized in
invertebrates, especially from the phyla Arthropoda and in vertebrates
from the class Amphibia. Linear cationic peptides with -helical
conformation share some common characteristics such as antimicrobial
activities at low micromolar concentrations and -helix formation in
hydrophobic environments. However, other features distinguish them such
as their disruptive activity toward eukaryotic cells, particularly red
blood cells, and their hydrophilic/hydrophobic amino acid distribution
along the structure. In arthropods, based on the source of the
antimicrobial peptides, these molecules could be roughly classified in
two types. The first type is cecropin-like peptides, which are
antimicrobial with low hemolytic activity acting as a part of the
insect immune defense system against the invasion of pathogenic
microorganisms. This type of molecule is mainly found in the hemolymph
of various arthropods such as sarcotoxin A in house fly (4), cecropins
in lepidoptera (3), and spinigerin in termites (5). The second type is
melittin-like peptides, which are antimicrobial with hemolytic activity
higher than that of the first type acting mainly as weapons for
capturing prey or as self-defense against other animals. This type of
peptide is mostly found in the venom glands of bees (6), wasps (7), spiders (8), ants (9), and scorpions (10, 11). Amphipathic -helical
peptides cause mainly the disruption of cell membranes by molecular
mechanisms depending principally on the charge distribution of the
peptide and on the chemical composition of the cell membranes. In the
order Arachnida, the biological function of the linear amphipathic
peptides may play an important role in capturing insects by dissipating
ion and voltage gradients across the membrane of excitable cells (8)
and as a defense mechanism against external pathogens (10) or possible
microbial infection after digestion caused by decomposition of the prey
(8). In this work, we report the isolation and chemical
characterization of five amphiphilic peptides (oxyopinins) and one
neurotoxin (Oxytoxin 1) from the venom of the spider Oxyopes
kitabensis. Oxyopinins are the largest linear cationic amphipathic
peptides from the venom of spiders that have been chemically
characterized thus far. We have analyzed their membrane lytic
activities in biological and in artificial phospholipid vesicles and
their mode of action in insect cells.
For comparative purposes we have included here a discussion of the
effects of the pandinins, extracted from the venom of the scorpion
Pandinus imperator. Additionally, we have demonstrated a
positive cooperativity effect of oxyopinins with that of neurotoxic peptides found in spider venom.
 |
EXPERIMENTAL PROCEDURES |
Biological Materials--
O. kitabensis crude venom
was purchased from SpiderPharm (Yarnell, AZ). Endoproteinase
Glu-C (EC 3.4.21.19) was from Sigma Chemical Co. (St. Louis, MO).
L- -Phosphatidylcholine
(PC)1 and
L- -phosphatidic acid (PA) from egg yolk were purchased
from Nacalai Tesque (Osaka, Japan). Phosphatidylethanolamine (PE) from Escherichia coli was from Doosan Serdary Research
Laboratories (Toronto, Canada). All phospholipids were of reagent grade
with purity higher than 98%. The microbial strains E. coli
(ATCC 11775) and Bacillus subtilis (ATCC 1175) were obtained
from the American Type Culture Collection. Staphylococcus
aureus (IAM 1098, from the Institute of Applied Microbiology
Culture Collection, University of Tokyo) was obtained from the Suntory
Institute for Fundamental Research. Pandinins and -paluIT1
were obtained according to Corzo et al. (11, 12).
Isolation of Oxyopinins and Oxytoxin--
O.
kitabensis crude venom (70 µl) was resuspended in 0.1% aqueous
trifluoroacetic acid containing 10% acetonitrile (CH3CN), and the insoluble material was removed by centrifugation at 14,000 × g for 5 min. The supernatant was used directly for HPLC
separation. The diluted venom was fractionated using a reverse-phase
semipreparative C18 column (5C18MS, 10 × 250 mm, Nacalai Tesque, Japan) equilibrated in 0.1% trifluoroacetic
acid and eluted with a linear gradient of acetonitrile from 0 to 60%
in 0.1% trifluoroacetic acid, run for 60 min at a flow rate of 2 ml/min. Effluent absorbance was monitored at 215 nm. Fractions with
antimicrobial (oxyopinins) or insecticidal (oxytoxin) activity were
further fractionated by cation exchange HPLC on a TSK-gel sulfopropyl
column (Tosoh SP-5PW, 7.5 × 75 mm, Japan). The column was
equilibrated with 5 mM sodium phosphate buffer, pH 6.5, containing 30% CH3CN. A linear gradient from 10 mM to 1.0 M sodium chloride was applied using
the same buffer and run at 1 ml/min. The peptides were finally purified
by a C4 reverse-phase column (4.6 × 250 mm, Nacalai
Tesque, Japan) using the same gradient as that for HPLC described above but with HFBA as an ion pairing instead of trifluoroacetic acid, run at
a flow rate of 1 ml/min.
Sequence Analysis--
Oxyopinins (Oxki1-5) and oxytoxin
(OxyTx1) were reduced with tributylphosphine (Nacalai Tesque, Japan)
and were alkylated with 4-vinyl-pyridine (Wako, Japan), in 0.5 M NaHCO3 buffer (pH 8.3) for 2 h at
37 °C in the dark prior to sequencing. The molecular masses of
oxyopinins did not change after reduction and alkylation. However, the
mass of the pyridylethylated peptide OxyTx1, 9,109.4 Da, exceeded that
of the native peptide by 1,050 Da, indicating the presence of
five disulfide bonds. All peptides were directly sequenced on a
Shimadzu PPSQ-10 automated gas-phase sequencer. The spider peptides
were dissolved in 30 µl of a 37% CH3CN solution and
applied to trifluoroacetic acid-treated glass fiber membranes, precycled with Polybrene (Aldrich, Milwaukee, WI). Data were recorded on a Shimadzu CR-7A integrator.
Enzymatic Digestions--
The peptides were subjected to
enzymatic hydrolysis. Hydrolysis with type XVII-B endoproteinase Glu-C
from Staphylococcus aureus V8 was carried out in 0.1 M sodium bicarbonate buffer (pH 7.6), at 37 °C for
3 h, using a 1:20 (w/w) enzyme to substrate ratio. The
endoproteinase digest was fractionated by reverse-phase HPLC using a
C4 column (250 × 4.6 mm, Nacalai Tesque, Japan) and a
linear gradient of acetonitrile in 0.1% aqueous trifluoroacetic acid.
The endoproteinase fractions were analyzed by MALDI-TOF MS, and
chemically sequenced.
Mass Spectrometry--
MALDI mass spectra were obtained on a
PerSeptive Voyager Elite time-of-flight (TOF) spectrometer (PerSeptive
Biosystems Inc., League City, TX) equipped with a model VSL-337ND
nitrogen laser (Laser Science, Cambridge, MA). The accelerating voltage
in the ion source was set to 20 kV, and data were acquired in the
positive linear mode of operation. Time-to-mass conversion was achieved by external and/or internal calibration using standards of bradykinin (m/z 1061.2), bovine pancreatic beta insulin
(m/z 3496.6), bovine pancreatic insulin
(m/z 5734.5), and ubiquitin
(m/z 8565.8) (Sigma). All experiments were
performed using -cyano-4-hydroxycinnamic acid (Aldrich) as the matrix.
Peptide Synthesis of Oxyopinins--
Oxki1 was chemically
synthesized by a solid-phase method using the Fmoc methodology on an
Applied Biosystems 433 A peptide synthesizer. Fmoc-Gln(tBu)-PEG resin
(Watanabe Ltd., Hiroshima, Japan) was used to provide a free
carboxyl at the C terminus of synthetics Oxki1-OH and Oxki2b-OH.
Chemical synthesis, cleavage, and deprotection of peptide resins were
performed according to the instructions from the 1999 Novabiochem
peptide synthesis handbook. The crude synthetic peptide was dissolved
in a 30% aqueous acetonitrile solution and separated by reverse-phase
HPLC on a semipreparative C18 column (10 × 250 mm,
Nacalai Tesque, Japan). Cation exchange chromatography and
C4 reverse-phase HPLC, as described above, were further
used to purify the synthetic peptides. The structural identity of the
synthetic and natural peptides was verified by co-elution experiments
using capillary zone electrophoresis and cation exchange HPLC. The mass
identity between synthetic and natural peptides was verified by
MALDI-TOF mass spectrometry.
Circular Dichroism (CD) Measurements--
CD spectra were
obtained on a Jasco J-725 spectropolarimeter (Jasco, Japan). The
spectra were measured from 260 to 180 nm in 10 mM potassium
phosphate buffer, pH 7.2, and in 60% TFE, pH 7.1, at room temperature,
with a 1-mm path-length cell. Data were collected at 0.1 nm with a scan
rate of 100 nm/min and a time constant of 0.5 s. The concentration
of the peptides was 40 µg/ml. Data were the average of 10 separate
recordings and were analyzed by the method of Bohm et al.
(13).
Antimicrobial and Hemolytic Assays--
Detection and isolation
of oxyopinins was done following plate growth inhibition of E. coli and B. subtilis by vacuum-dried HPLC fractions
that were resuspended in 20 µl of distilled water according to Corzo
et al. (11). Growth inhibition curves and minimal inhibitory
concentrations (MIC) were obtained using pure peptides at
concentrations of 1.6, 3.1, 6.2, 12.5, 25, and 50 µM.
Briefly, the inoculum was prepared from fresh bacteria cultures. Serial
dilutions of peptides were arranged, and an aliquot of cell suspension
was added to each vial. The final volume in each vial was 100 µl, and
the cell count was 1.2 × 106 CFU/ml for S. aureus and 1.6 × 106 colony-forming units/ml for
E. coli. The final peptide concentration ranged from 1.6 to
50 µM. After 16-18 h of incubation at 37 °C, the
optical density (OD) of each vial was measured at 630 nm in an
enzyme-linked immunosorbent assay reader (Bio-Rad, model 450, Hercules,
CA). The positive control contained only the bacterial suspension, and
the negative control contained only sterile culture medium. The MIC
values were defined as the lowest concentration of peptide at which
100% growth inhibition was observed. Hemolytic activity was determined
by incubating suspensions of sheep, pig, or guinea pig red blood cells
with serial dilutions of each selected peptide. Red blood cells (10%
v/v) were rinsed several times in PBS by centrifugation for 3 min at
3000 × g until the OD of the supernatant reached the
OD of the control (PBS only). Red blood cells were counted by an
hematocytometer and adjusted to approximately 7.7 × 106 ± 0.3 × 106 cells/ml. Red blood
cells were then incubated at room temperature for 1 h in 10%
Triton X-100 (positive control), in PBS (blank), or with amphipathic
peptides at concentrations of 1.6, 3.1, 6.2, 12.5, 25, and 50 µM. The samples were then centrifuged at 10,000 × g for 5 min; the supernatant was separated from the pellet, and its absorbance was measured at 570 nm. The relative optical density
compared with that of the suspension treated with 10% Triton X-100
defined the percentage of hemolysis.
Artificial Vesicles--
Small unilamellar vesicles (SUVs)
containing calcein were prepared according to Wieprecht et
al. (14). Calcein leakage from vesicles was monitored
fluorometrically using a Hitachi fluorescence spectrophotometer
(F-4500, Tokyo, Japan) by measuring the time-dependent increase in fluorescence of calcein release. As calcein leaks from the
vesicles by the disrupting activity of oxyopinins it becomes diluted
and therefore dequenched, and an increase in fluorescence is recorded
(excitation = 490 nm, emission = 520 nm). A final volume of
0.95 ml of SUVs was placed in a stirred cuvette at room temperature. An
aliquot of peptide solution (50 µl) was added to the cuvette. The
percentage of calcein released by the addition of peptides was
evaluated by the equation: 100 × (F Fo)/(Ft Fo), where F is the
fluorescence intensity achieved by the peptides. Fo is the fluorescence intensity observed
without the peptides, and Ft is the fluorescence
intensity corresponding to 100% calcein release determined by the
addition of 50 µl of 10% Triton X-100. The phosphorus content in
phospholipid vesicles was estimated by spectrophotometric analysis
(15).
Hemocytes--
The hemolymph of Spodoptera litura
larvae was collected by an aseptic puncture in the prolegs in 1.5-ml
polypropylene vials containing 0.5 ml of an anticoagulant solution
(16). The diluted hemolymph was centrifuged at 720 × g
for 5 min. The supernatant was discarded, and the pellet containing the
hemocytes was washed twice with the anticoagulant solution. Hemocytes
were resuspended in Grace's insect media (Invitrogen). Eighty
microliters of Grace's medium containing hemocytes was added to each
vial containing 20 µl of the cultured medium with serial dilutions of
peptides. The final suspension (100 µl) contained ~2 × 106 hemocytes/ml (total hemocytes count). Viability of
hemocytes was detected after 60 min of incubation at room temperature
by a lactic dehydrogenase-based assay kit (Sigma). The positive control (100% hemolysis) was determined by applying a lytic solution (supplied with the kit) to disrupt hemocyte cells. The hemocytes in Grace's medium were used as a negative control.
Sf9 Insect Cell Culture and Electrophysiological
Recordings--
Insect Sf9 cells (Spodoptera
frugiperda cells) were kept in culture in Grace's media at
27 °C as previously reported (17). The membrane resistance was
monitored by recording the ionic current elicited by test pulses
applied every second from a holding potential of 0 mV under whole-cell
patch clamp, using an Axopatch-1D amplifier (Axon Instruments,
Burlingame, CA). Currents were filtered at 5 KHz and sampled at 100 µs per point, with a TL1 interface (Axon Instruments). Electrodes
were pulled from borosilicate glass (KIMAX 51) to a final resistance of
2 M . The bath solution contained (millimolar): 115 NaCl,
10 CaCl2, 10 HEPES-NaOH buffer, pH 7.2. The internal
solution contained (millimolar): 90 KF, 30 KCl, 10 EGTA, 10 HEPES-KOH
buffer, pH 7.2. Oxyopinins were diluted in the bath solution before
being added to the recording chamber.
Microinjection Assay--
Insect paralytic activity was
evaluated with a previously described microinjection assay using
S. litura (tobacco cutworm) early third-instar larvae (2-3
mg) (18). Larvae were injected in the pronotum with glass
capillary pipettes and up to 300 nl of neurotoxic and/or cytolytic
peptide resuspended in water and placed in 55 mm-diameter plastic Petri
dishes with an artificial diet. Paralytic and lethal effects were
observed at different time intervals up to 24 h. The lethal dose
corresponding to 50% of mortality (LD50) was calculated by
probit analysis (19).
Statistical Analysis--
The last significant difference method
was used to determine whether statistically significance differences
occurred among the mean values obtained.
 |
RESULTS |
Purification and Sequence Analysis of Oxyopinins and
Oxytoxin--
The crude venom of O. kitabensis was
fractionated using reverse-phase HPLC (Fig.
1). Sixty fractions were manually
collected and vacuum-dried. Dried HPLC fractions were resuspended in
distilled water and assayed for antimicrobial activity toward E. coli and B. subtilis. Fractions 40, 41, and 45 showed
antimicrobial activity toward both E. coli and B. subtilis, and they were further fractionated by cation-exchange
chromatography (CE). Fraction 45 yielded a pure peptide under CE, and
it was named oxyopinin1 (Oxki1). Fractions 40 and 41 produced two
antimicrobial peptides each by CE, and they were named oxyopinins 2, 3, 4, and 5 (Oxki2-5). All five antimicrobial peptides (Oxki1-5) were
further resolved under reverse-phase HPLC conditions using HFBA for ion
pairing. Oxyopinins were obtained in homogenous form as analyzed by
capillary zone electrophoresis (data not shown). Direct Edman
degradation sequencing of Oxki1 allowed unequivocal identification of
the first 42 amino acid residues. The complete amino acid sequence of
Oxki1 was obtained after its enzymatic digestion with endoproteinase
Glu-C. The endoproteinase digestion of Oxki1 yielded two fragments that
permitted the full identification of all amino acid residues in Oxki1
(Fig. 2A). Oxyopinin1 is
composed of 48 amino acid residues, and its molecular mass determined
by mass spectrometry was 5221.2 Da, in good agreement with the
theoretically expected molecular weight of 5221.3. Direct sequencing of
Oxki2 to Oxki5 permitted the identification of their 37 amino acid
residues and their theoretical molecular weights were 4126.9, 4146.9, 4064.8, and 4156.9, which also agree with their masses found by mass
spectrometry of 4127.1, 4146.9, 4064.7, and 4156.8 Da. Because the
oxyopinins 2, 3, 4, and 5 had similar number of residues and they were
identical in at least 27 of 37 amino acid residues (see Fig.
2A), they were named oxyopinins 2a, 2b, 2c, and 2d (Oxki
2a-2d). All four Oxki2 analogs were digested with Glu-C, and, as
expected from their primary structure, only Oxki2b and Oxki2c produced
peptide fragments, which is a confirmatory result of the primary
structure obtained. Analysis of known antimicrobial peptide sequences
using the data base (bbcm1.univ.trieste.it/~tossi/pag1.htm) showed
that at least 240 -linear peptides from animals and plants have been
reported thus far. From the entire repertoire of peptides, we have
chosen some antimicrobial and insecticidal -helical peptides from
arthropods and frogs to compare their structural similarities. The
primary structure of Oxyopinin 1 is 29% identical to that of the frog
antimicrobial peptide dermaseptin and to that of the ant insecticidal
peptide ponericinL2. Similarly, the Oxyopinin 2 analogs are about 20%
identical to that of the amphipathic peptide ponericinL2 (Fig.
2A).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
RP-HPLC chromatogram of crude O. kitabensis venom. The numbers 40,
41, and 45 represent HPLC fractions that gave
positive results in antimicrobial bioassays. The asterisk
represents the major insecticidal neurotoxin OxyTx1 from the crude
venom.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 2.
Amino acid sequences of oxyopinins and
oxytoxin (OxyTx1). A, alignment of oxyopinins with
known amphipathic antimicrobial peptides. The sequences compared are:
esculentin 1 from Rana esculenta (24); cecropin A from
Hyalophora cecropia (3); sarcotoxin IA from Sarcohaga
peregrina (4); dermaseptin from Phyllomedusa sauvagii
(23), pandinins from P. imperator (11); lycotoxins from
Lycosa carolinensis (8); hadrurin from Hadrurus
aztecus (10); ponericins from Pachycondyla goeldii (9).
Percentage of identity is shown based in either oxyopinin 1 or
oxyopinin 2a. B, alignment of oxytoxin with known
insecticidal neurotoxins. The sequences compared are; Tx2-1, Tx2-5,
Tx2-6, and Tx4(6-1) from P. nigriventer (20, 21). The
percent identity is shown based on OxyTx1. The sequence alignment was
obtained from www.ch.embnet.org/software/ClustalW.html. Gaps
(hyphens) have been introduced to enhance
similarities.
|
|
A new neurotoxic peptide named Oxytoxin 1 (OxyTx1) was also isolated
from the same spider venom. OxyTx1 is the major paralytic neurotoxin of
O. kitabensis, which elutes from HPLC at the position indicated with an asterisk in Fig. 1. It contains 69 amino
acid residues with a molecular mass of 8059.2 Da closely packed by five
disulfide bridges (Fig. 2B). OxyTx1 is a basic peptide
(calculated pI 9.28) with a carboxylated free C-terminal residue as
suggested by mass spectrometry data. OxyTx1 has some sequence
similarity to insecticidal neuropeptides isolated from the crude venom
of the Brazilian spider Phoneutria nigriventer (20) (Fig.
2B). Tx4(6-1), from P. nigriventer, is an
insecticidal toxin that is non-toxic to mice (21) and slows down the
inactivation of the sodium channel in insect CNS via binding to
receptor site 3 (22). Similarly to Tx4(6-1), OxyTx1 is an insecticidal
toxin that is non-toxic to mice up to 1 µg/20-g mouse, but it is
surmised to be specific for sodium channels of insects (complete
characterization to be described elsewhere). The use of mixtures of
OxyTx1 with oxyopinins increased the lethality effect of individual
components, as will be briefly described below.
Circular Dichroism and Peptide Synthesis of Oxyopinins--
The
secondary structures of Oxki1 and Oxki2 analogs were analyzed by
circular dichroism spectrometry in phosphate buffer and in 60%
solution of TFE. Aqueous solutions of TFE promote hydrogen bonding, and
it is considered to mimic a cell membrane environment (25). Oxyopinins
adopted unordered structures in potassium phosphate buffer with
negative ellipticities around 195-200 nm (data not shown). Oxyopinins
adopted -helix structures with negative ellipticities at 208 and 222 nm in 60% TFE (Fig. 3). Similar CD
spectra of oxyopinins in hydrophobic environments have been previously
observed with other amphiphilic peptides containing -helix
structures (11, 23, 26, 27).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Circular dichroism spectra of native
oxyopinins in 60% TFE. The secondary structures of Oxki1
and Oxki2 analogs were analyzed by circular dichroism spectrometry in
phosphate buffer and in 60% solution of TFE. The concentration of the
peptides was 40 µg/ml. Data are the average of 10 separate
recordings.
|
|
To conduct biological experiments and to confirm the primary and
secondary structures of oxyopinins, Oxki1 and Oxki2b were chemically
synthesized. Despite the fact that Oxki1 and Oxki2b are peptides of 48 and 37 amino acid residues long, the final yield of their chemical
synthesis was 44 and 56%. In our experience, these good yields are
probably a consequence of their linear nature, which would favor amino
acid assembly throughout the automatic synthesis. Shortly after their
chemical synthesis and purification, co-elution analysis of the
synthetic peptides with their respective native forms was verified.
Mass spectrometry determinations confirmed the identity of the
synthetic and native oxyopinins (data not shown). Further biological
experiments were carried out using the synthetic oxyopinins with the
prevailing names of Oxki1 and Oxki2.
Antimicrobial Assays--
The antibacterial and hemolytic
activities of oxyopinins were compared with those of pandinins (Pin1
and Pin2), which are -linear antimicrobial peptides isolated from
the venom of the scorpion P. imperator. Pandinin 1 is a low
hemolytic and antimicrobial peptide. Pandinin 2 is a highly hemolytic
and antimicrobial peptide with biological and structural
characteristics similar to melittin (11). The minimal inhibitory
concentrations against S. aureus were 6.2, 6.2, 25, and 1.6 µM for Oxki1, Oxki2, Pin1, and Pin2, respectively (Fig.
4A). The minimal inhibitory
concentrations against E. coli were 1.6, 12.5, 50, and 6.2 µM for Oxki1, Oxki2, Pin1, and Pin2, respectively (Fig.
4B). Oxki1 showed strong antimicrobial activity toward both
E. coli and S. aureus. Oxki2 and the comparative controls Pin1 and Pin2 were more lytic to S. aureus (Gram-positive) than to E. coli. The high
antimicrobial activity of Oxki1 toward E. coli could be of a
great significance as a potential antibiotic, because most of the
antimicrobial peptides already discovered usually had low activity
toward Gram-negative bacteria.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Antimicrobial activity of oxyopinins and
pandinins. A, S. aureus; B,
E. coli. Data are the average of three independent
experiments. Error bars represent the standard
deviation.
|
|
Hemolytic Assays and Calcein Leakage from Phospholipid
Vesicles--
The content of PC in mammalian red blood cells varies
depending on the animal source. The percentages of PC of the total
membrane phospholipids in guinea pig, pig, and sheep red blood cells
are 41, 23, and 1%, respectively (28, 29). The hemolytic activities of
Oxki1, Oxki2, and Pin1 in guinea pig, pig, and sheep erythrocytes were
lower compared with that of the hemolytic activities of Pin2 (Fig.
5, A-C). With pig and sheep
blood the hemolytic activity of Oxki1 was slightly higher than that of
Oxki2, whereas with all blood cells the hemolytic activity of Oxki2 was
higher than that of the peptide Pin1. Pig and guinea pig erythrocytes
whose cell membranes are rich in PC were more susceptible to the
hemolysis induced by all four arachnic peptides. Sheep erythrocytes
were less susceptible to the hemolysis induced by all four amphipathic peptides. Moreover, at higher concentrations of sheep erythrocytes (approximately 6.6 × 107 cells/ml) non-significant
hemolytic activity of Oxki1, Oxki2, and Pin1 was observed using peptide
concentrations up to 50 µM, except for Pin2.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Hemolytic activity and percent release of
calcein from artificial vesicles following the addition of oxyopinins
and pandinins. A, guinea pig; B, pig;
C, sheep; D, phosphatidic acid; E,
phosphatidylethanolamine; and F, phosphatidylcholine. Data
are the average of three independent experiments for the pig and sheep
red blood cells and the average of two independent experiments for
guinea pig red blood cells and the artificial vesicles. Error
bars represent the standard deviation.
|
|
A comparison of pandinins and oxyopinins in their ability to release
calcein from SUVs with different lipid composition is shown in Fig. 5
(D-F). Oxki1 was more effective in releasing calcein from
zwitterionic and anionic vesicles when compared with Oxki2 and
pandinins. All four amphipathic peptides were more lytic toward PC
vesicles than toward PE and PA vesicles. Although pandinin 2 is shorter
than Oxki2, it was more effective than Oxki2 in releasing calcein from
artificial vesicles. The disrupting activities of Oxki1 and Oxki2 to
the three different phospholipid vesicles demonstrated that the mode of
action of these peptides might be phospholipid-mediated. Moreover,
oxyopinins are able to bind to the phospholipid bilayers with different
specificities and eventually can produce leakage of their content.
Overall, oxyopinin 1 was more effective in disrupting both biological
and artificial vesicles than oxyopinin 2.
Hemocytes and Whole-cell Patch Clamp of Sf9 Insect
Cells--
Because oxyopinins were obtained from the venom gland of a
predator specialized in insect prey capture; we looked for a possible significant biological effect in insect cells. Therefore, the membrane
integrity of insect hemocytes from S. litura larvae in the
presence of oxyopinins and pandinins was measured. However, no
cytolytic or membrane disruption effect using up to 200 µM amphipathic peptides was observed when compared with
both positive and negative controls under the assay conditions. The
positive control gave a clear reaction produced by the release of
cytoplasmic lactate dehydrogenase from insect hemocytes. Although the
cell surface of insect hemocytes could be a target of amphipathic
peptides, because they are negatively charged (30), hemocytes respond to foreign molecules by adhesion mechanisms that could subdue the
activity of pore-forming peptides. Moreover we specifically tested the
effect of oxyopinins on the membrane resistance of S. frugiperda pupal ovary cells (Sf9). After the whole-cell
configuration of the patch clamp was established, the stability of the
membrane was monitored with the delivery of 10 mV/3.5-ms test voltage pulses applied every second from the holding potential (HP) of 0 mV.
Fig. 6A shows the last three
superimposed currents elicited by the test pulses, after compensation
of the stray capacitance. The traces show the typical
resistor-capacitor passive electrical behavior of biological
membranes (31). The large capacitive current transients mark the
beginning and the end of the test pulses. Once the stability of the
membrane was verified, Oxki1 was added to the bath solution at a final
concentration of 1 µM. Fig. 6B shows that the
addition of Oxki1 produced a sudden fall of the membrane resistance,
which is seen by the increase in both the holding current (labeled
I1) and the current during the pulse (labeled
I2). Interestingly, it was observed that
(a) the holding current transiently changes its sign
(further more detailed studies are needed to determine the reason of
this change) and (b) after its initial increase, both the
holding and the pulse currents relaxed to a smaller value
(I1 dropped from 0.6 to 0.01 nA) where they remained stable
for some minutes (variable from cell to cell) until the cell was
finally lost (not shown). The latter is best seen in Fig.
6C, which shows the membrane resistance during each pulse.
The arrow points to the addition of Oxki1.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Oxki1 on Sf9 cells.
A, control currents elicited by three test pulses of 10
mV/3.5 ms. B, currents after the addition of 1 µM Oxki1 to the external solution, rate of pulsing was 1 Hz. C, membrane resistance versus time of the
whole traces in B. D, current elicited by
stepping up the membrane potential from 50 to +30 mV (labeled
I3) after the initial 10-mV test pulse. The
horizontal scale bar indicates 2.3 ms in panels
A, B, and D. The vertical scale
bar indicates 1.1 nA in A, 0.93 nA in B, and
1.7 nA in D. E, current versus voltage
relationship of the traces in D (circles) and the traces
recorded 3 min later (not shown in D, triangles).
HP = 0 mV, Cm = 8 picofarads. The dotted
line in the traces indicates the zero current level.
|
|
Finally, to explore the properties of the conductance pathway open by
Oxki1, a current versus voltage (I-V) relationship was constructed (Fig. 6D) by stepping up the membrane potential
from 50 to +30 mV in 10-mV increments after a former 10-mV test
pulse (applied to verify the constancy of the membrane resistance
during the I-V). Fig. 6E shows the I-V relationship of both
the traces in D (circles) and the traces
(triangles) recorded 3 min later. Fig. 6E
illustrates that Oxki1 drops the membrane resistance by opening a
non-selective (reversal potential = 0 mV) ohmic (approximately linear) pathway in the membrane.
It is important to mention that qualitatively similar results were also
observed with all other four native oxyopinins 2a-d tested, including
the initial drop in membrane resistance followed by the subsequent
partial relaxation shown in Fig. 6C. It is also important to
mention that appropriate controls were conducted to show that the
effects registered were due neither to buffer components nor to
mechanical artifacts.
Insecticidal Cooperativity between Oxyopinins and Neurotoxic
Peptides--
It is well known that the primary function of spider
venom is to paralyze their prey (32). Therefore, a possible toxic
effect of oxyopinins in insects was tested. Oxki1, Oxki2, and Pin2 were injected into S. litura larvae. Upon peptide injection the
larvae presented necrotic spots after 60-90 min post-injection at the site of needle insertion. Furthermore, depending on the concentration of peptide injected, the size of such a necrotic spot would increase with time. The LD50 values of Oxki1, Oxki2, and Pin2 were
166.3 ± 13.4 (n = 3), 500.4 ± 26.3 (n = 3), and 553.3 ± 90.4 (n = 3) nmol/g of larvae, respectively (Fig. 7).
The insecticidal activities of oxyopinins were compared with those of
the spider neurotoxins OxyTx1 and -paluIT1 (12). OxyTx1 is
insecticidal to the lepidopteran larvae S. litura with an
LD50 of 5.1 ± 0.5 (n = 2) nmol/g of
larvae (Fig. 7). Also, the neurotoxin -paluIT1 is lethal to the same insect with a LD50 of 1.8 ± 0.2 (n = 2) nmol/g of larvae (Fig. 7). Comparative studies of the insecticidal
activity of oxyopinins to those of the spider neurotoxins showed that
the latter were from 30 to 90 times more potent than the insecticidal
activity of the oxyopinin 1. Because the paralysis inflicted by the
venom on insects is considered to be a synergistic effect caused by several factors, such as neurotransmitters, neuropeptides, and enzymes,
the insecticidal activity of the neurotoxins OxyTx1 and -paluIT1
were tested in the presence of the individual oxyopinins. The relative
concentrations of the pure peptides Oxki1, Oxki2, and OxyTx1 in the
soluble venom, as estimated by the chromatogram areas obtained from
Fig. 1, were 7.2, 12.0, and 4.1%, respectively. Based on these data,
the area ratio of amphipathic peptides to OxyTx1 is roughly 4.6. Therefore, a molar mixture 1:5 (neurotoxin:Oxki1) was prepared for use
for injection into S. litura larvae. Although the
concentration of Oxki1 was lower than the total of Oxki2a-d peptides
in the crude venom, individually, Oxki1 was the most potent among all
five amphipathic peptides. The LD50 values of the
OxyTx1/Oxki1 and -paluIT1/Oxki1 mixtures containing molar ratios 1:5
were 0.4 ± 0.1 (n = 2) and 0.1 ± 0.01 (n = 2), respectively. They were significant lower
(p < 0.05, n = 2) than the
LD50 values of the individual neurotoxins, suggesting the
existence of a cooperative lethality effect when mixtures of both
neurotoxins and Oxki1 were used for bioassay. Additionally, mixtures at
molar ratio 1:1 (neurotoxin:Oxki1) were also tested (see the legend of
Fig. 7). In these conditions, the LD50 values for the pair
OxyTx1/Oxki1 and -paluIT1/Oxki1 were 5.8 ± 1.6 (n = 2) and 1.6 ± 0.1 (n = 2),
respectively. They were not significant different (p > 0.05, n = 2) from those of the insecticidal activities
of pure neurotoxins OxyTx1 and -paluIT1. Furthermore, the time
required for the larvae to become paralyzed or eventually to die, under
the effect of mixtures (ratio 1:5) of neurotoxin/amphipathic peptides,
were greatly reduced (Fig. 8). After the
injection of the mixtures the S. litura larvae showed a
faster paralytic effect. Both neurotoxins OxyTx1 and -paluIT1 act
gradually over several hours depending on the concentration injected
into the insects (Fig. 8, A and B). Therefore,
co-injection of neurotoxins and amphipathic peptides enhanced the
paralytic and lethal activity of neurotoxins in a time- and
dose-dependent manner.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Insecticidal activity of oxyopinins and
neurotoxins toward insect paralysis. Dose response of the
individual and the mixtures of amphipathic and neurotoxic peptides. The
concentration on the abscissa scale corresponds to nanomoles
of individual peptide per gram of larvae for the peptides Pin2, Oxki1,
Oxki2, -paluIT1, and OxyTx1. In the case of the peptide mixtures
OxyTx1/Oxki1 and -paluIT1/Oxki1, the scale corresponds to the values
based on the concentration of the neurotoxins. The lethal dose
corresponding to 50% of mortality (LD50) was calculated by
probit analysis. The LD50 values are Oxki1, 166.3 ± 13.4 (n = 3); Oxki2, 500.4 ± 26.3 (n = 3); Pin2, 553.3 ± 90.4 (n = 3); -PaluIT1, 1.8 ± 0.2 (n = 2); OxyTx1,
5.1 ± 0.5 (n = 2); -PaluIT1/Oxki1(1:5),
0.1 ± 0.01 (n = 2); OxyTx1/Oxki1(1:5), 0.4 ± 0.1 (n = 2); -PaluIT1/Oxki1(1:1), 1.6 ± 0.1 (n = 2); and OxyTx1/Oxki1(1:1), 5.8 ± 1.6 (n = 2). Each point represents the average
of two to three independent experiments using at least ten S. litura larvae. Error bars represent the standard
deviation.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Insecticidal cooperativity of neurotoxins and
oxyopinins. A, insecticidal effect over time of the
individual neurotoxin OxyTx1 and the peptide mixtures OxyTx1/Oxki1,
OxyTx1/Oxki2, and OxyTx1/Pin2. (Concentration used: 0.5 nmol of OxyTx1
plus 2.5 nmol of amphipathic peptide per gram of larvae.) B,
insecticidal effect over time of individual neurotoxin -paluIT1 and
the peptide mixtures -paluIT1/Oxki1, -paluIT1/Oxki2, and
-paluIT1/Pin2. (Concentration used: 0.5 nmol of -paluIT1 plus 2.5 nmol of amphipathic peptide per gram of larvae.) A control sample of
2.5 nmol of amphipathic peptide/g of larvae did not produce paralysis
of insects (data not shown). Each point represents the
average of two independent experiments using at least ten S. litura larvae. Error bars represent the standard
deviation.
|
|
 |
DISCUSSION |
Analysis of the primary structure of all five oxyopinins shows the
absence of the amino acid residues tryptophan and tyrosine. The
only aromatic residue present in these amphipathic peptides was
phenylalanine, which has the lowest molar extinction of all aromatic
amino acids. Consequently, oxyopinins were detected at low UV
wavelengths. Oxyopinin 1 and the analogs of oxyopinin 2 were
eluted at a high percentage of acetonitrile from the reverse-phase HPLC
column (Fig. 1) indicating their hydrophobic character. Oxyopinin 1 is
more hydrophobic than the oxyopinin 2 analogs, and this characteristic could reflect possible differences in their biological activity. The
degree of hydrophobicity and the distribution of cationic charges in
oxyopinins certainly play a crucial role in determining the cytotoxic
and the antimicrobial effects. These characteristics also should define
their ability to interact with membrane phospholipids of different
compositions and chemical structures. Oxyopinins belong to a large
group of -helical antimicrobial peptides that may contain two
different amphipathic -helices separated by flexible hinge regions
such as Val22-Leu23-Pro24 and
Gly19-Val20-Gly21, respectively.
Separated segments of -helices have been determined in the
antimicrobial peptides cecropin A (33) and sarcotoxin A (34). For the
first peptide, Pro23 was described as the kink-forming
point of the structure, whereas for the second a segment of four
residues in positions Gly24-Ile27 were the ones
disrupting the continuity of the of -helices. The length occupied by
these 37- to 48-amino acid peptides was estimated to be 55.5-72 Å (1.5 Å per residue), which is therefore enough to span at least once
through the 30-Å-thick phospholipid bilayer of the biological
membranes, facilitating the formation of a pore-like structure.
Although an extended shape of oxyopinins would be large enough to span
twice through the lipid bilayer, the apparent absence of a secondary
structure, such as disulfide bridges, -turns, or -sheets would
preclude such physical occurrence. The possibility that oxyopinins form
helicoidal structures in a lipidic environment seems to be plausible,
as shown by the results of Fig. 3, obtained in the presence of TFE.
Natural (35-37) and artificial linear (38, 39) amphipathic peptides
larger than 24 amino acid residues can form well-defined membrane ion
channels. Thus, oxyopinins are more likely pore-forming peptides. This
view is partially supported by the experiments performed with the
Sf9 ovarian cell membranes (Fig. 6), but it was not directly
proven here. Moreover, it has been recently observed that the
pore-forming peptide magainin2 and PGLa form a heterodimer, and
this heterodimer exhibited membrane permeabilization activity an order
of magnitude higher compared with the monomeric species (40).
Therefore, there is an additional possibility of synergistic
interaction between Oxki1 and Oxki2, either for increasing the
cytolytic activity or for enhancement of the neurotoxic effects of the venom.
For amphipathic peptides several mechanisms of membrane
permeabilization have been proposed. Cecropin and dermaseptin are suggested to disrupt membranes by the so-called "carpet-like" mechanism (41). In the case of alamethicin, the "barrel-stave" model of pore formation was proposed (42), and in the case of magainin,
a peptide-lipid toroidal pore (43, 44). The oxyopinins 1 and 2 act on
bacterial cells and also lyse red blood cell membranes (Figs. 4 and 5).
The results in vivo correspond well with in vitro studies, which demonstrated that peptides bind and permeate both negatively charged and zwitterionic vesicles. However, the mode of
action could differ between acidic and zwitterionic phospholipids. The
dose dependence curves obtained with these peptides assayed on PC
vesicles are sigmoidal, and peptides permeabilize vesicles at a low
peptide-to-lipid ratio, which is consistent with the pore-forming
model. On the other hand, the curves for PA and PE vesicles required a
5 to 10 times higher peptide-to-lipid ratio for vesicle
permeabilization. The latter is consistent with a non-pore-forming
process whereby cationic peptides first adsorbed onto the negatively
charged membrane surface to form a carpet-like layer and then (when a
threshold concentration of peptides bound to membrane has been reached)
form transient holes, capable of producing complete lysis. It is
thought that the density or size of the lipid headgroup present in the
bilayers plays an important function in this behavior. The headgroups
of PE or PA are substantially smaller than that of PC (45, 46).
Therefore, PC-rich membranes would be less dense or less compact
permitting the insertion of oxyopinins into the bilayers.
Interestingly, the addition of PE to PC artificial vesicles has
resulted in a decrement of the disruptive activity of some natural
antimicrobial peptides such as alamethicin (46) and PGLa (47).
Moreover, protegrins have a deleterious effect toward human
erythrocytes that are rich in PC lipids but non-toxic to those of pigs
that are less rich in PC lipids (29, 48). Oxyopinins have a higher
propensity to lyse PC vesicles rather than PE and PA vesicles. This
concept correlates well with the increasing hemolytic activity observed
in red blood cells containing higher amounts of PC (Fig. 5,
A-C). The phospholipid composition of cell membranes may
influence parameters of the pore structure, for example, the increase
of membrane fluidity shortens the pore lifetime (44). Therefore, the
different lytic potency of oxyopinins against erythrocytes of different
lipid composition also suggest the pore-forming mechanism.
Wolf spiders are vagabonds that lie in ambush or freely hunt their prey
(49). Although the antimicrobial activity of oxyopinins from O. kitabensis could be just fortuitous, it is unlikely that bacteria
were the exclusive targets of these amphipathic molecules from a venom
gland specialized in prey capture. Despite the fact that several
antimicrobial peptides are produced by organisms throughout the
phylogenetic tree (50), the biological function of antimicrobial
-linear peptides makes sense when they are produced and excreted on
the skin of amphibians or produced inside cells specialized in host
immunity. In the case of oxyopinins, because of their origin, it seems
that the main targets are insect cells rather than microorganisms. The
insecticidal activity of amphipathic molecules has been previously
shown by Orivel et al. (9). They found that some amphipathic
molecules from the ant Pachycondyla goeldii are insecticidal
to house crickets. Yan and Adams (8) proposed that the biological
function of linear amphipathic peptides from spiders might play an
important role in capturing insect prey by dissipating ion and voltage
gradients across the membranes of excitable cells. The whole-cell patch
clamp experiments in Sf9 cells showed that oxyopinins can
effectively disturb the membrane potential of insect cells leading to
its complete lysis at higher concentrations (Fig. 6). This effect was
also observed with the enlargement of necrotic spots in larvae after
post-injection of oxyopinins. However, it seems that not all the insect
cell lines are susceptible to oxyopinins as demonstrated here with the
hemocytes, which were not susceptible to lysis in the presence of high
concentrations of these peptides. Therefore, the detrimental effect of
oxyopinins could be more pronounced in insect cell lines containing a
substantial amount of PC lipids in their membranes. This hypothesis is
supported by the enhanced hemolytic activity of red blood cells with a
higher content of PC.
The insecticidal cooperativity between neurotoxins and oxyopinins is
not a particular characteristic of these amphipathic molecules from
spider venoms. Insecticidal cooperativity was observed in the mixtures
OxyTx1/Pin2 and -paluIT1/Pin2 (Fig. 8), where Pin2 is an amphipathic
molecule from the scorpion P. imperator venom. Additionally,
positive cooperativity in venoms of spiders has been observed between
polyamines and neuropeptides (51) as well as between adenosine
triphosphate and venom toxins (52). Therefore, other arachnid venoms
may contain amphipathic molecules used for potentiation of their
neurotoxic activities, as demonstrated for the case of scorpions (53).
Recently Elazar et al. (54) have shown that lower levels of
neurotoxin AaIT (35-fold lower) are needed to kill or paralyze
lepidoptera larvae when the neurotoxin AaIT is expressed internally by
baculovirus infection than that when AaIT is injected directly to the
hemolymph of the larvae. This phenomenon is called toxin potentiation.
Usually upon prey injection, the venom components have to overcome
accessibility barriers and internal processes of degradation
before reaching their target (55). The larger components and the
hydrophilic molecules from spider venom would find it more difficult to
diffuse toward their receptor sites. Therefore, neurotoxin diffusion
toward their target molecules, inside the prey, might be facilitated by
the presence of amphipathic peptides acting as co-factors of insect
toxicity. Oxyopinins as well as other linear amphipathic peptides could
function as spreading factors, by clearing the way and helping the
larger neurotoxins to reach their receptor sites. Spreading factors
have been often observed in the venom of spiders or poisonous animals
such as snakes and lizards. However, the best known spreading factors
are enzymes like hyaluronidase and other proteases that degrade the
extracellular matrix molecules of tissues and disrupt cell membranes
spreading the deleterious effect over the injured tissue (56). The
hypothesis of oxyopinins as spreading factors or co-factors could
explain the positive insecticidal cooperativity of oxyopinins and the
neurotoxic peptides toward lepidoptera larvae. Oxyopinins,
therefore, are an additional ingredient in the lethal mixture of gland
venom components that are used by the spiders to achieve a quick and
effective mode of capturing their prey.
The antimicrobial properties of oxyopinins are certainly a model for
the design and development of alternative drugs to be use in the
therapeutic treatment of infection by pathogenic bacteria. Unfortunately, their cytolytic effect should still be addressed in this
context. In addition, the oxyopinins could be used to enhance the
insecticidal activity of genetically modified insect-specific baculoviruses in the field of biopesticides.
 |
ACKNOWLEDGEMENTS |
We are grateful to T. Maeda for insect
rearing and to Dr. Pierre Escoubas for helping with mass spectrometry analysis.
 |
Addendum |
During the original submission of this work,
Kuhn-Nentwig et al. (57) reported the antimicrobial peptide
structures of four cupiennins from the spider Cupiennius
salei (Ctenidae). Although these spiders are of a different genus
and from different geographic zones, it seems that they are
evolutionarily related.
 |
FOOTNOTES |
*
This work was supported by a grant from the Research for the
Future Program from the Japanese Society for the Promotion of Science
and by Grant z-005 from the National Council of Science and Technology
(to F. G. L. and L. D. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The amino acid sequences reported in this paper has
been submitted to the Swiss Protein Database under Swiss-Prot accession no. P83247 for Oxyopinin 1 (Oxki1), P83248 for Oxyopinin 2a
(Oxki2a), P83249 for Oxyopinin 2b (Oxki2b), P83250 for Oxyopinin
2c (Oxki2c), P83251 for Oxyopinin 2d (Oxki2d), and P83288 for Oxytoxin
1 (OxyTx1).
§
To whom correspondence should be addressed. Tel.: 81-75-962-8792;
Fax: 81-75-962-2115; E-mail: corzo@sunbor.or.jp.
Published, JBC Papers in Press, April 25, 2002, DOI 10.1074/jbc.M200511200
 |
ABBREVIATIONS |
The abbreviations used are:
PC, phosphatidylcholine;
PE, phosphatidylethanolamine;
PA, phosphatidic
acid;
CD, circular dichroism;
CZE, capillary zone electrophoresis;
MALDI-TOF MS, matrix-assisted laser desorption-ionization
time-of-flight mass spectrometry;
OD, optical density;
Oxki1, oxyopinin
1;
Oxki2a-d, oxyopinins 2a, 2b, 2c, and 2d;
Pin1, pandinin 1;
Pin 2, pandinin 2;
PBS, phosphate-buffered saline;
TFE, trifluoroethanol;
HFBA, hepta-fluorobutyric acid;
MIC, minimum inhibitory concentration;
SUV, small unilamellar vesicles;
Fmoc, N-(9-fluorenyl)methoxycarbonyl;
LD50, lethal
dose that kills 50% of the animals;
-paluIT1, insecticidal toxin
from the spider Paracoelotes luctuosus;
OxyTx1, insecticidal
toxin from the spider O. kitabensis;
HPLC, high performance
liquid chromatography;
CD, circular dichroism;
CE, cation-exchange
chromatography;
HP, holding potential;
AaIT, insect specific neurotoxin
from the venom of the scorpion Androctonus
australis.
 |
REFERENCES |
| 1.
|
Andreu, D.,
and Rivas, L.
(1998)
Biopolymers
47,
415-433
|
| 2.
|
Habermann, E.,
Jentsch, J.,
and Hoppe-Seyler's, Z.
(1967)
Physiol. Chem.
348,
37-50
|
| 3.
|
Steiner, H.,
Hultmark, D.,
Engstrom, A.,
Bennich, H.,
and Boman, H. G.
(1981)
Nature
292,
246-248
|
| 4.
|
Okada, M.,
and Natori, S.
(1985)
J. Biol. Chem.
260,
7174-7177
|
| 5.
|
Lamberty, M.,
Zachary, D.,
Lanot, R.,
Bordereau, C.,
Robert, A.,
Hoffmann, J. A.,
and Bulet, P.
(2001)
J. Biol. Chem.
276,
4085-4092
|
| 6.
|
Fennell, J. F.,
Shipman, W. H.,
and Cole, L. J.
(1968)
Proc. Soc. Exp. Biol. Med.
127,
707-710
|
| 7.
|
Nakajima, T.,
Yasuhara, T.,
Horikawa, R.,
Pisano, J. J.,
and Erspamer, V.
(1990)
Adv. Exp. Med. Biol.
247A,
215-220
|
| 8.
|
Yan, L.,
and Adams, M. E.
(1998)
J. Biol. Chem.
273,
2059-2066
|
| 9.
|
Orivel, J.,
Redeker, V., Le,
Caer, J. P.,
Krier, F.,
Revol-Junelles, A. M.,
Longeon, A.,
Chaffotte, A.,
Dejean, A.,
and Rossier, J.
(2001)
J. Biol. Chem.
276,
17823-17829
|
| 10.
|
Torres-Larios, A.,
Gurrola, G. B.,
Zamudio, F. Z.,
and Possani, L. D.
(2000)
Eur. J. Biochem.
267,
5023-5031
|
| 11.
|
Corzo, G.,
Escoubas, P.,
Villegas, E.,
Barnham, K. J., He, W.,
Norton, R. S.,
and Nakajima, T.
(2001)
Biochem. J.
359,
35-45
|
| 12.
|
Corzo, G.,
Escoubas, P.,
Stankiewicz, M.,
Pelhate, M.,
Kristensen, C. P.,
and Nakajima, T.
(2000)
Eur. J. Biochem.
267,
5783-5795
|
| 13.
|
Bohm, G.,
Muhr, R.,
and Jaenicke, R.
(1992)
Protein Eng.
5,
191-195
|
| 14.
|
Wieprecht, T.,
Apostolov, O.,
and Seelig, J.
(2000)
Biophys. Chem.
85,
187-198
|
| 15.
|
Bottcher, C. J. F.,
Van Gent, C. M.,
and Pries, C.
(1961)
Anal. Chim. Acta
24,
203-204
|
| 16.
|
Soderhall, K.,
and Smith, V. J.
(1983)
Dev. Comp. Immunol.
7,
229-239
|
| 17.
|
Gómez-Lagunas, F.,
Olamendi-Portugal, T.,
Zamudio, F.,
and Possani, L. D.
(1996)
J. Membr. Biol.
152,
49-56
|
| 18.
|
Escoubas, P.,
Palma, M. F.,
and Nakajima, T.
(1995)
Toxicon
33,
1549-1555
|
| 19.
|
Finney, D. J.
(1962)
Probit Analysis: A Statistical Treatment of the Sigmoid Response Curve
, pp. 318-323, Cambridge University Press, Cambridge
|
| 20.
|
Cordeiro, M. d. N.,
Diniz, C. R.,
Valentim, A. do C.,
von Eickstedt, V. R.,
Gilroy, J.,
and Richardson, M.
(1992)
FEBS Lett.
310,
153-156
|
| 21.
|
Figueiredo, S. G.,
Garcia, M. E.,
Valentim, A. C.,
Cordeiro, M. N.,
Diniz, C. R.,
and Richardson, M.
(1995)
Toxicon
33,
83-93
|
| 22.
|
de Lima, M. E.,
Stankiewicz, M.,
Hamon, A.,
de Figueiredo, S. G.,
Cordeiro, M. N.,
Diniz, C. R.,
Martin-Eauclaire, M. F.,
and Pelhate, M.
(2002)
J. Insect Physiol.
48,
53-61
|
| 23.
|
Mor, A.,
Nguyen, V. H.,
Delfour, A.,
Migliore-Samour, D.,
and Nicolas, P.
(1991)
Biochemistry
30,
8824-8830
|
| 24.
|
Simmaco, M.,
Mignogna, G.,
Barra, D.,
and Bossa, F.
(1993)
FEBS Lett.
324,
159-161
|
| 25.
|
Sonnichsen, F. D.,
Van Eyk, J. E.,
Hodges, R. S.,
and Sykes, B. D.
(1992)
Biochemistry
31,
8790-8798
|
| 26.
|
Batista, C. V. F.,
Rosendo da Silva, L.,
Sebben, A.,
Scaloni, A.,
Ferrara, L.,
Paiva, G. R.,
Olamendi-Portugal, T.,
Possani, L. D.,
and Bloch, C., Jr.
(1999)
Peptides
20,
679-686
|
| 27.
|
Wong, H.,
Bowie, J. H.,
and Carver, J. A.
(1997)
Eur. J. Biochem.
247,
545-557
|
| 28.
|
Nelson, G. J.
(1967)
Biochim. Biophys. Acta
144,
221-232
|
| 29.
|
White, D. A.
(1973)
in
Form and Function of Phospholipids
(Ansell, B.
, Dawson, R. M. C.
, and Hawthorne, J. N., eds)
, p. 454, Elsevier, Amsterdam
|
| 30.
|
Takle, G.,
and Lackie, A. M.
(1985)
J. Cell Sci.
75,
207-214
|
| 31.
|
Hille, B.
(1992)
Ionic Channels of Excitable Membranes
, 2nd Ed.
, Sinauer Associates, Inc., Sunderland, MA
|
| 32.
|
Friedel, T.,
and Nentwig, W.
(1989)
Toxicon
27,
305-316
|
| 33.
|
Steiner, H.,
Andreu, D.,
and Merrifield, R. B.
(1988)
Biochim. Biophys. Acta
939,
260-266
|
| 34.
|
Iwai, H.,
Nakajima, Y.,
Natori, S.,
Arata, Y.,
and Shimada, I.
(1993)
Eur. J. Biochem.
217,
639-644
|
| 35.
|
Silvestro, L.,
Gupta, K.,
Weiser, J. N.,
and Axelsen, P. H.
(1997)
Biochemistry
36,
11452-11460
|
| 36.
|
Christensen, B.,
Fink, J.,
Merrifield, R. B.,
and Mauzerall, D.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
5072-5076
|
| 37.
|
Duclohier, H.,
Molle, G.,
and Spach, G.
(1989)
Biophys. J.
56,
1017-1021
|
| 38.
|
Agawa, Y.,
Lee, S.,
Ono, S.,
Aoyagi, H.,
Ohno, M.,
Taniguchi, T.,
Anzai, K.,
and Kirino, Y.
(1991)
J. Biol. Chem.
266,
20218-20222
|
| 39.
|
Higashimoto, Y.,
Kodama, H.,
Jelokhani-Niaraki, M.,
Kato, F.,
and Kondo, M.
(1999)
J. Biochem. (Tokyo)
125,
705-712
|
| 40.
|
Hara, T.,
Mitani, Y.,
Tanaka, K.,
Uematsu, N.,
Takakura, A.,
Tachi, T.,
Kodama, H.,
Kondo, M.,
Mori, H.,
Otaka, A.,
Nobutaka, F.,
and Matsuzaki, K.
(2001)
Biochemistry
40,
12395-12399
|
| 41.
|
Sansom, M. S.
(1991)
Prog. Biophys. Mol. Biol.
55,
139-235
|
| 42.
|
Mak, D. O.,
and Webb, W. W.
(1995)
Biophys J.
69,
2323-2336
|
| 43.
|
Matsuzaki, K.,
Murase, O.,
Fujii, N.,
and Miyajima, K.
(1996)
Biochemistry
35,
11361-11368
|
| 44.
|
Matsuzaki, K.,
Nakamura, A.,
Murase, O.,
Sugishita, K.,
Fujii, N.,
and Miyajima, K.
(1997)
Biochemistry
36,
2104-2111
|
| 45.
|
Heller, W. T., He, K.,
Ludtke, S. J.,
Harroun, T. A.,
and Huang, H. W.
(1997)
Biophys. J.
73,
239-244
|
| 46.
|
Chen, F. Y.,
Lee, M. T.,
and Huang, H. W.
(2002)
Biophys. J.
82,
908-914
|
| 47.
|
Blazyk, J.,
Wiegand, R.,
Klein, J.,
Hammer, J.,
Epand, R. M.,
Epand, R. F.,
Maloy, W. L.,
and Kari, U. P.
(2001)
J. Biol. Chem.
276,
27899-27906
|
| 48.
|
Huang, H. W.
(2000)
Biochemistry
39,
8347-8352
|
| 49.
|
Foelix, R. F.
(1996)
Biology of Spiders
, 2nd Ed.
, pp. 7-9, Oxford University Press, New York
|
| 50.
|
Silva, P. I., Jr.,
Daffre, S.,
and Bulet, P.
(2000)
J. Biol. Chem.
275,
33464-33470
|
| 51.
|
Adams, M. E.,
Herold, E. E.,
and Venema, V. J.
(1989)
J. Comp. Physiol. [A]
164,
333-342
|
| 52.
|
Chan, T. K.,
Geren, C. R.,
Howell, D. E.,
and Odell, G. V.
(1975)
Toxicon
13,
61-66
|
| 53.
|
Herrmann, R.,
Moskowitz, H.,
Zlotkin, E.,
and Hammock, B. D.
(1995)
Toxicon
33,
1099-1102
|
| 54.
|
Elazar, M.,
Levi, R.,
and Zlotkin, E.
(2001)
J. Exp. Biol.
204,
2637-2645
|
| 55.
|
Herrmann, R.,
Fishman, L.,
and Zlotkin, E.
(1990)
Insect Biochem.
20,
625-637
|
| 56.
|
Veiga, S. S.,
Zanetti, V. C.,
Braz, A.,
Mangili, O. C.,
and Gremski, W.
(2001)
Braz. J. Med. Biol. Res.
34,
843-850
|
| 57.
|
Kuhn-Nentwig, L.,
Muller, J.,
Schaller, J.,
Walz, A.,
Dathe, M.,
and Nentwig, W.
(2002)
J. Biol. Chem.
277,
11208-11216
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Kozlov, A. A. Vassilevski, A. V. Feofanov, A. Y. Surovoy, D. V. Karpunin, and E. V. Grishin
Latarcins, Antimicrobial and Cytolytic Peptides from the Venom of the Spider Lachesana tarabaevi (Zodariidae) That Exemplify Biomolecular Diversity
J. Biol. Chem.,
July 28, 2006;
281(30):
20983 - 20992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wullschleger, W. Nentwig, and L. Kuhn-Nentwig
Spider venom: enhancement of venom efficacy mediated by different synergistic strategies in Cupiennius salei
J. Exp. Biol.,
June 1, 2005;
208(11):
2115 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Deslouches, S. M. Phadke, V. Lazarevic, M. Cascio, K. Islam, R. C. Montelaro, and T. A. Mietzner
De Novo Generation of Cationic Antimicrobial Peptides: Influence of Length and Tryptophan Substitution on Antimicrobial Activity
Antimicrob. Agents Chemother.,
January 1, 2005;
49(1):
316 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wullschleger, L. Kuhn-Nentwig, J. Tromp, U. Kampfer, J. Schaller, S. Schurch, and W. Nentwig
CSTX-13, a highly synergistically acting two-chain neurotoxic enhancer in the venom of the spider Cupiennius salei (Ctenidae)
PNAS,
August 3, 2004;
101(31):
11251 - 11256.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|